Prevention

Researchers in the United States and South Korea recently studied the use of an experimental nanoparticle treatment that acts as a decoy to stop and kill the influenza virus.

Marcos Pires, PhD, assistant professor at Lehigh University, explains whether or not his team’s strategy to use immunotherapy as a substitute for antibiotics will vary from patient to patient.

There is a stigma that incoming refugees pose a health risk to European communities. In order to assess the risk of possible outbreaks and jump-start prevention, the European Centre for Disease Prevention and Control (ECDC) recommends implementing a multi-step Syndromic Surveillance system.

Drug maker Melinta has submitted their new antibiotic Baxdela for review by the US Food and Drug Administration, with the hopes that it will bring a new treatment option for people suffering from methicillin-resistant Staphylococcus aureus (MRSA).

The World Health Organization (WHO) has released their Global Tuberculosis Report for 2016, emphasizing that today’s global actions and investments are falling far short of what is needed to stop the worldwide tuberculosis (TB) epidemic.

Susan Kline, MD, MPH, associate professor of medicine, Division of Infectious Diseases and International Medicine, medical director for Infection Control, lead physician for Antibiotic Stewardship, University of Minnesota, discusses how restricting use of vancomycin impacted the emergence of vancomycin-resistant enterococci.

Seven cases of Candida auris have been identified within the United States, according to a report in the latest Centers for Disease Control and Prevention’s Morbidity and Mortality Weekly Report.

Rapid syphilis screening tests can be useful in community-based facilities, according to the results of five studies presented in a mini-plenary on September 22 at the Centers for Disease Control and Prevention 2016 STD Prevention Conference in Atlanta, Georgia.

At the Centers for Disease Control and Prevention's 2016 STD Prevention Conference, researchers discussed three novel prevention strategies for HIV, other STIs, and unintended pregnancies.

Vikas Gupta, PharmD, BCPS, director of Clinical Strategy at Becton Dickinson, explains his team’s unique approach to understanding multidrug-resistant infections.

With new US Food and Drug Administration rules on antibiotics in agriculture taking effect at the start of 2017, challenges remain when it comes to the reduction of antimicrobial use in livestock.

Methicillin-resistant Staphylococcus aureus (MRSA) causes more than 11,000 deaths in the United States each year and a new study shows how this pathogen is able to evade last-line antibiotics.

Public-health experts recommend that the seasonal influenza vaccine be available in more non-medical settings in hopes that with increased accessibility, more people will choose to get vaccinated.

Researchers have not been able to develop a vaccine for hepatitis C, which causes 700,000 deaths around the world annually, and now, a new study shows why developing a vaccine for the virus has been so difficult.

The monoclonal antibody, ibalizumab, has proven to be both safe and effective in treating patients who are infected with multi-drug-resistant HIV-1 and have been previously treated.

At the ID Week meeting in New Orleans, Louisiana, a trio of speakers addressed some of the outpatient challenges regarding antimicrobial stewardship.

Compared with bigger institutions, community hospitals are lacking when it comes to educating healthcare workers and providing effective infection control programs, which is compromising patient care, according to a presentation at ID Week 2016.

Researchers estimate that there are more cases of sclerosing panencephalitis (SSPE), a fatal measles complication, than previous thought.

“The number of people who experience the devastating effects of preventable infectious diseases like measles, diphtheria, and whooping cough is at an all-time low," according to the Centers for Disease Control and Prevention (CDC).

The probability of a measles epidemic occurring in Texas increases as the number of children exempt from receiving the measles vaccine continues to grow.

A trio of speakers addressed the global problem of antibiotic resistance and how the problem is especially vexing in Africa, Asia, and Latin America, at the annual conference of the Infectious Diseases Society of America in New Orleans, Louisiana.

During ID Week, Robert Read, MD, from University Hospital Southampton in Southampton, UK, discussed how a better understanding of meningococcal disease has led to more effective treatment strategies.

A symposium at the annual meeting of the Infectious Diseases Society of America in New Orleans, Louisiana, highlighted initiatives designed to curb the spread of antibiotic resistance.

Rita Olans, DNP, CPNP-PC, APRN-BC, assistant professor at MGH Institute of Health Professions, discusses the importance of incorporating staff nurses in a healthcare setting's antimicrobial stewardship program.

Vikas Gupta, PharmD, BCPS, director of Clinical Strategy at Becton Dickinson, discusses his research on the national prevalence of multidrug-resistant organisms.